16 published brand profiles in this category. Cite the individual brand profile for brand-specific facts.
Anaptys Bio - Strategic stewardship of financial collaborations to deliver shareholder value AnaptysBio exclusively manages the financial collaborations from Jemperli with GSK and imsidolimab with Vanda, with a focus on protecting and returning their value to stockholdersVirtual operating modelLess than ~10 FTEs operating as contractors to support the essential functions of a public companyAnticipate annualized
Arcutis Biotherapeutics - Get more information about Arcutis’ late-stage development and commercialization of topical treatments for immune-mediated dermatological diseases.
Aurinia Pharmaceuticals - Aurinia Pharmaceuticals Inc. is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs.
Celgene Corporation - Celgene Corporation is an immunology company headquartered in Summit, NJ, founded in 1986.
Connect Biopharma - Connect Biopharma is a global biopharmaceutical company dedicated to improving the lives of patients with inflammatory diseases.
Corbus Pharmaceuticals - Corbus is a clinical-stage pharmaceutical company developing treatments for cancer and obesity. Learn how our team is advancing novel therapies under investigation, aimed at addressing significant unmet medical needs and improving patient outcomes.
Dermira - Dermira is an immunology company headquartered in Menlo Park, CA, founded in 2007.
Galapagos NV - Galapagos NV is an immunology company headquartered in Mechelen, Belgium, founded in 1999.
Kymera Therapeutics - Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Principia Biopharma - Principia Biopharma is an immunology company headquartered in South San Francisco, CA, founded in 2008.
Prometheus Biosciences - Prometheus Biosciences is an immunology company headquartered in San Diego, CA, founded in 2016.
Roivant Sciences - We have worked to ensure an open, diverse, and inclusive culture, while building a leadership team, board of directors and broader employee base that reflects these values. Our Vants have conducted 12 positive Phase 3 trials since 2019, and launched VTAMA®, (tapinarof) cream, 1%, for the topical treatment of plaque psoriasis in adults In 2022, we launched VTAMA®, (tapinarof) cream, 1%, for the topical treatment of plaque psoriasis in adults. Organon acquired Dermavant in 2024 Pipeline Advancing
Takeda Pharmaceuticals - Takeda is a patient-focused, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future.
Theravance Biopharma - Theravance Biopharma aims to transform the treatment of serious diseases through the discovery and development of organ-selective medicines. Learn more.
Ventyx Biosciences - Ventyx Biosciences is a clinical-stage biopharmaceutical company developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases. Our expertise in medicinal chemistry, structural biology, and immunology enables the discovery of differentiated small molecule therapeutics for conditions with high unmet medical need, and our extensive experience in clinical development allows the rapid progression of these drugs through clinical trials. Our lead portf
Viela Bio - Viela Bio is an immunology company headquartered in Gaithersburg, MD, founded in 2018.